Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine to prevent postoperative delirium after hip or knee arthroplasty
ChiCTR2500114488Phase 4Not yet recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) and complications of surgical procedures comparing Normal saline intranasal (placebo) with Intranasal dexmedetomidine (2 arms). Primary endpoint: Incidence of postoperative delirium (POD). Planned start Dec 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)complications of surgical procedures
Beyond the preview
Go deeper on ChiCTR2500114488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114488.